Analyses of circulating metabolites in large prospective epidemiological studies could lead to improved prediction and better biological understanding of coronary heart disease (CHD). We performed a mass spectrometry-based non-targeted metabolomics study for association with incident CHD events in 1,028 individuals (131 events; 10 y. median follow-up) with validation in 1,670 individuals (282 events; 3.9 y. median follow-up). Four metabolites were replicated and independent of main cardiovascular risk factors [lysophosphatidylcholine 18:1 (hazard ratio [HR] per standard deviation [SD] increment?=?0.77, P-value
Notes
Cites: Twin Res Hum Genet. 2013 Feb;16(1):317-2923137839
Cites: PLoS Genet. 2011 Jul;7(7):e100219321829377
Cites: Eur Heart J. 2013 Jul;34(26):1982-923242195
Cites: PLoS One. 2013;8(8):e7184623967253
Cites: Nat Genet. 2013 Nov;45(11):1345-5224097064
Cites: Ann Intern Med. 2014 Jan 21;160(2):122-3124592497
Cites: Circulation. 2014 May 6;129(18):1821-3124622385
Cites: Am J Epidemiol. 2014 Jul 15;180(2):129-3924966222